康亚药业 (872320.OC)

+ 收藏

利润表(康亚药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2024年年报2024年中报2023年年报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 会员可见会员可见会员可见会员可见65,877,345.8824,338,455.50
 营业收入(元) 会员可见会员可见会员可见会员可见65,877,345.8824,338,455.50
二、营业总成本(元) 会员可见会员可见会员可见会员可见66,391,266.9427,403,417.28
 营业成本(元) 会员可见会员可见会员可见会员可见24,735,804.4810,167,409.10
 研发费用(元) 会员可见会员可见会员可见会员可见16,737,241.765,677,564.81
 营业税金及附加(元) 会员可见会员可见会员可见会员可见1,078,810.97447,310.21
 销售费用(元) 会员可见会员可见会员可见会员可见15,183,733.706,591,972.75
 管理费用(元) 会员可见会员可见会员可见会员可见8,272,114.464,340,598.80
 财务费用(元) 会员可见会员可见会员可见会员可见383,561.57178,561.61
  其中:利息费用(元) 会员可见会员可见会员可见会员可见589,033.53294,716.22
三、其他经营收益
 加:投资收益(元) 会员可见会员可见会员可见会员可见1,234,554.67528,753.68
 资产处置收益(元) 会员可见会员可见会员可见会员可见7,095.72-
 资产减值损失(元) 会员可见会员可见会员可见会员可见-1,074,457.81-129,427.92
 信用减值损失(元) 会员可见会员可见会员可见会员可见622,963.571,455,086.33
 其他收益(元) 会员可见会员可见会员可见会员可见4,800,257.621,900,398.48
四、营业利润(元) 会员可见会员可见会员可见会员可见5,076,492.71689,848.79
 加:营业外收入(元) 会员可见会员可见会员可见会员可见9,310.4831.13
 减:营业外支出(元) 会员可见会员可见会员可见会员可见107,054.9231,706.11
五、利润总额(元) 会员可见会员可见会员可见会员可见4,978,748.27658,173.81
 减:所得税费用(元) 会员可见会员可见会员可见会员可见-973,564.19224,304.83
六、净利润(元) 会员可见会员可见会员可见会员可见5,952,312.46433,868.98
(一)按经营持续性分类
  持续经营净利润(元) 会员可见会员可见会员可见会员可见5,952,312.46433,868.98
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 会员可见会员可见会员可见会员可见5,772,740.41457,613.40
  少数股东损益(元) 会员可见会员可见会员可见会员可见179,572.05-23,744.42
 扣除非经常性损益后的净利润(元) 会员可见会员可见会员可见会员可见1,893,846.05-1,559,241.09
七、每股收益
 一、基本每股收益(元) 会员可见会员可见会员可见会员可见0.090.01
 二、稀释每股收益(元) 会员可见-会员可见---
九、综合收益总额(元) 会员可见会员可见会员可见会员可见5,952,312.46433,868.98
 归属于母公司所有者的综合收益总额(元) 会员可见会员可见会员可见会员可见5,772,740.41457,613.40
 归属于少数股东的综合收益总额(元) 会员可见会员可见会员可见会员可见179,572.05-23,744.42
公告日期 2025-08-272025-04-292024-08-272024-04-292023-08-302023-06-07
审计意见(境内) -标准无保留意见-标准无保留意见--
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院